Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty
Last updated on July 2021Recruitment
- Recruitment Status
- Terminated
- Estimated Enrollment
- 80
Summary
- Conditions
- Abdominoplasty
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 23 years and 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03429556
- Collaborators
- Not Provided
- Investigators
- Study Director: Joan-En Lin Allergan
Get Well Soon